COMPASS Pathways plc (CMPS)
USD 3.93
(-6.43%)
USD 3.93
(-6.43%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -136.91 Million USD | -24.02% |
| 2022 | -110.4 Million USD | -32.66% |
| 2021 | -83.22 Million USD | -61.93% |
| 2020 | -51.39 Million USD | -142.66% |
| 2019 | -21.17 Million USD | -69.39% |
| 2018 | -12.5 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -47.89 Million USD | -10.56% |
| 2024 Q2 | -43.32 Million USD | -12.31% |
| 2024 Q1 | -38.57 Million USD | 0.43% |
| 2023 Q1 | -31.78 Million USD | 1.25% |
| 2023 FY | -137.44 Million USD | -24.5% |
| 2023 Q4 | -38.73 Million USD | -13.73% |
| 2023 Q3 | -34.06 Million USD | -4.28% |
| 2023 Q2 | -32.66 Million USD | -2.76% |
| 2022 Q2 | -27.25 Million USD | -7.22% |
| 2022 Q1 | -25.42 Million USD | 10.25% |
| 2022 FY | -110.4 Million USD | -32.66% |
| 2022 Q4 | -32.19 Million USD | -26.06% |
| 2022 Q3 | -25.53 Million USD | 6.31% |
| 2021 FY | -83.22 Million USD | -61.93% |
| 2021 Q4 | -28.32 Million USD | -30.11% |
| 2021 Q3 | -21.76 Million USD | -11.47% |
| 2021 Q2 | -19.52 Million USD | -43.57% |
| 2021 Q1 | -13.6 Million USD | -18.08% |
| 2020 Q1 | -8.7 Million USD | -18.81% |
| 2020 Q4 | -11.51 Million USD | 14.56% |
| 2020 Q3 | -13.48 Million USD | 23.77% |
| 2020 Q2 | -17.68 Million USD | -103.18% |
| 2020 FY | -51.39 Million USD | -142.66% |
| 2019 Q1 | -2.71 Million USD | 0.0% |
| 2019 FY | -21.17 Million USD | -69.39% |
| 2019 Q4 | -7.32 Million USD | -16.86% |
| 2019 Q3 | -6.27 Million USD | -72.11% |
| 2019 Q2 | -3.64 Million USD | -34.38% |
| 2018 FY | -12.5 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 127.027% |
| Addus HomeCare Corporation | 90.95 Million USD | 250.533% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 1543.836% |
| Amedisys, Inc. | 156.39 Million USD | 187.547% |
| American Oncology Network, Inc. | -49.15 Million USD | -178.551% |
| Astrana Health, Inc. | 84.61 Million USD | 261.818% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 1796.222% |
| IMAC Holdings, Inc. | -6.37 Million USD | -2047.578% |
| biote Corp. | 28.65 Million USD | 577.786% |
| Cryo-Cell International, Inc. | -12.3 Million USD | -1012.798% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 221.476% |
| DocGo Inc. | 15.05 Million USD | 1009.46% |
| The Ensign Group, Inc. | 255.36 Million USD | 153.617% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 319.569% |
| InnovAge Holding Corp. | -23.18 Million USD | -490.677% |
| Assure Holdings Corp. | -20.08 Million USD | -581.8% |
| The Joint Corp. | -2.07 Million USD | -6504.595% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 27.607% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | -771.888% |
| ModivCare Inc. | -139.94 Million USD | 2.163% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 324230.013% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | -1500.8% |
| Option Care Health, Inc. | 314.59 Million USD | 143.522% |
| P3 Health Partners Inc. | -167.86 Million USD | 18.433% |
| P3 Health Partners Inc. | -167.86 Million USD | 18.433% |
| The Pennant Group, Inc. | 25.16 Million USD | 643.999% |
| Surgery Partners, Inc. | 328 Million USD | 141.744% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -4641.621% |
| Talkspace, Inc. | -23.2 Million USD | -489.939% |
| Talkspace, Inc. | -23.2 Million USD | -489.939% |
| The Oncology Institute, Inc. | -77.01 Million USD | -77.775% |
| The Oncology Institute, Inc. | -77.01 Million USD | -77.775% |